Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 4 min ago

Oncology

5,305 studies560 in 7 days2,549 in 30 days

Filters
Type
Date
Clear

Latest

5,305 studies

  1. GPR183-mediated immune cell positioning and function: an integrative perspective across ligand gradients, tissue environments, and disease stages
    Xinrui Lin, Xinyu Dong, Zhe Jiang +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  2. LncRNA–protein interactions: molecular switches for the precise regulation of innate immunity
    Chenhao Yang, Yanxia Feng, Chengfang Li +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Case Report: Immune-related colitis complicated by Clostridioides difficile-associated colitis
    Wenjuan Chen, Wanqian Zhang, Chaoqun Sun +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  4. 53L10 T-cell engager tribody for immunotherapy of multiple solid tumors
    Margherita Passariello, Martina Belardo, Toshikazu Inoue +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective
    JiLi Xu, Lili Sui, Wenzhe Yang +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  6. PD-1/PD-L1 inhibitors combined with chemotherapy or as monotherapy versus chemotherapy alone or observation in triple-negative breast cancer: a systematic review and updated meta-analysis incorporating long-term survival data
    Bing Guan, Yawen Chen, Rong Zhou +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  7. Merkel Cell Polyomavirus and DNA Damage Response
    Sara Passerini, Sara Messina, Ugo Moens +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  8. Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study.
    Xing Su, Jing Li, Xiaowei Hu
    JMIR public health and surveillancePeer-reviewedCC BYFull textOncologyEurope PMC
  9. Lighting up cancer: latest discoveries in ruthenium(ii) polypyridyl complexes for anticancer photodynamic therapy.
    Pei Yi Tan, Ke Hui Lee, Kuan Teng Tan +6
    RSC advancesPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  10. Cancer-derived lactic acid as a potential upstream contributor to tumor hypoxia
    Ning Kang, Yuzhuo Wang
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  11. Drosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during Development
    Nam-Sung Moon, Maxim Frolov, Eun-Jeong Kwon +6
    Developmental CellPeer-reviewedLicence not statedFull text77 citedOncologyHAL
  12. Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression
    Christophe Quemerais, Christine Jean, Alexia Brunel +14
    Cancer LettersPeer-reviewedCC BY6 citedOncologyHAL
  13. Embryonic origin of cancer in newborn twins
    Barbara Walkowiak, Sadie Baskind, Manas Dave +15
    Nature CommunicationsPeer-reviewedCC BY 4.0Full text1 citedOncologyCrossrefPMC
  14. Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable metastatic melanoma: a pilot biomarker-driven trial
    Ayana T. Ruffin, Crystal L. Mallow, Brian M. Olson +24
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  15. Rapid Whole Genome Sequencing Enhances Pediatric Cancer Diagnosis
    Aditi Vedi, Jamie Trotman, Joao M. L. Dias +37
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textOncologyCrossref
  16. RhoA Y42C drives cell plasticity and PD-1-mediated immune evasion of diffuse gastric cancer
    Kyung-Pil Ko, Sangmin Kim, Jinho Jang +11
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossrefEurope PMCPMC
  17. HiFIseek: Gene-specific enrichment of high-impact mutations in associated genomic regions
    Rafael Riudavets Puig, Denise G O'Mahony, Ina Skaara Brorson +3
    PLOS Computational BiologyPeer-reviewedCC BYFull textOncologyPLOSEurope PMC
  18. Inhibition and Knockdown of Monocarboxylate Transporter 1 Induce L-Lactate Accumulation in T-Cell Acute Lymphoblastic Leukemia Cells
    Yudai Suganuma, Yuto Mukai, Noriyuki Matsumoto +5
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textOncologyJ-STAGE
  19. Explainable AI framework for skin lesion imaging based cancer detection
    Sivarama Prasad Tera, Ravikumar Chinthaginjala, Priya Natha +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  20. Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis
    Zihui Liu, Yiting Gu, Huanfang Fan +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  21. Integrated multi-omic analysis characterizes an IFNγ-responsive-to-myeloid-suppressive immune continuum in immune-active hepatocellular carcinoma
    Luping Lin, Ningna Weng, Huaying Lai +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  22. A genetic algorithm–optimized EWMA control chart integrating machine learning-based risk prediction for multistage thyroid cancer treatment monitoring
    Mohammad Rasouli, Elham Rahimi, Arshia Ilaty
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  23. Efficacy and safety of MEK inhibitors for NF1-associated symptomatic, inoperable plexiform neurofibromas: A systematic review and meta-analysis
    Sudarshawn Damodharan, James Tonsgard
    PLOS OnePeer-reviewedCC BY 4.0Full textClinical trials & evidence synthesisOncologyPharmacology & toxicologyPLOS
  24. Decoding the Sequence Determinants of DNA Cleavage in Histidine-Containing Copper(II) Metallopeptides
    Ana B. Caballero, Olga Iranzo, Patrick Gamez
    ChemRxivPreprintCC BY-NC-NDFull textOncologyChemRxiv
  25. Cu(II) complexes based on morpholine-substituted thiosemicarbazones show reduced toxicity in normal cells
    Bartłomiej Rogalewicz, Marcin Świątkowski, Magdalena Iwan +11
    ChemRxivPreprintCC BYFull textOncologyChemRxiv